These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7671255)

  • 41. Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines.
    Mantovani F; Banks L
    Oncogene; 1999 Jun; 18(22):3309-15. PubMed ID: 10362351
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
    Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
    Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation.
    DeWeese TL; Walsh JC; Dillehay LE; Kessis TD; Hedrick L; Cho KR; Nelson WG
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):145-54. PubMed ID: 9054890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.
    Kessis TD; Slebos RJ; Nelson WG; Kastan MB; Plunkett BS; Han SM; Lorincz AT; Hedrick L; Cho KR
    Proc Natl Acad Sci U S A; 1993 May; 90(9):3988-92. PubMed ID: 8387205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of tetraploidy through loss of p53 and upregulation of Plk1 by human papillomavirus type-16 E6.
    Incassati A; Patel D; McCance DJ
    Oncogene; 2006 Apr; 25(17):2444-51. PubMed ID: 16369493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of the HPV16 E7 gene generates proliferation in stratified squamous cell cultures which is independent of endogenous p53 levels.
    Blanton RA; Coltrera MD; Gown AM; Halbert CL; McDougall JK
    Cell Growth Differ; 1992 Nov; 3(11):791-802. PubMed ID: 1334693
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7.
    Demers GW; Foster SA; Halbert CL; Galloway DA
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4382-6. PubMed ID: 8183918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human papillomavirus type 16 E6 inhibits p21(WAF1) transcription independently of p53 by inactivating p150(Sal2).
    Parroche P; Touka M; Mansour M; Bouvard V; Thépot A; Accardi R; Carreira C; Roblot GG; Sylla BS; Hasan U; Tommasino M
    Virology; 2011 Sep; 417(2):443-8. PubMed ID: 21791360
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymerase eta and p53 jointly regulate cell survival, apoptosis and Mre11 recombination during S phase checkpoint arrest after UV irradiation.
    Cleaver JE; Bartholomew J; Char D; Crowley E; Feeney L; Limoli CL
    DNA Repair (Amst); 2002 Jan; 1(1):41-57. PubMed ID: 12509296
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development.
    Pan H; Griep AE
    Genes Dev; 1994 Jun; 8(11):1285-99. PubMed ID: 7926731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways.
    Song S; Gulliver GA; Lambert PF
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2290-5. PubMed ID: 9482878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Marker genes for cytotoxic exposure: p53.
    Montenarh M
    Stem Cells; 1995 May; 13 Suppl 1():136-41. PubMed ID: 7488939
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint.
    Thomas JT; Laimins LA
    J Virol; 1998 Feb; 72(2):1131-7. PubMed ID: 9445009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity.
    Sedman SA; Hubbert NL; Vass WC; Lowy DR; Schiller JT
    J Virol; 1992 Jul; 66(7):4201-8. PubMed ID: 1318401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells.
    Dalal S; Gao Q; Androphy EJ; Band V
    J Virol; 1996 Feb; 70(2):683-8. PubMed ID: 8551603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of apoptosis in human keratinocytes containing mutated p53 alleles and its inhibition by both the E6 and E7 oncoproteins.
    Magal SS; Jackman A; Pei XF; Schlegel R; Sherman L
    Int J Cancer; 1998 Jan; 75(1):96-104. PubMed ID: 9426696
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HPV16 E6 confers p53-dependent and p53-independent phenotypes in the epidermis of mice deficient for E6AP.
    Shai A; Nguyen ML; Wagstaff J; Jiang YH; Lambert PF
    Oncogene; 2007 May; 26(23):3321-8. PubMed ID: 17130828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuroepithelial carcinomas in mice transgenic with human papillomavirus type 16 E6/E7 ORFs.
    Arbeit JM; Münger K; Howley PM; Hanahan D
    Am J Pathol; 1993 Apr; 142(4):1187-97. PubMed ID: 8386443
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Degradation of p53 only is not sufficient for the growth stimulatory effect of human papillomavirus 16 E6 oncoprotein in human embryonic fibroblasts.
    Ishiwatari H; Hayasaka N; Inoue H; Yutsudo M; Hakura A
    J Med Virol; 1994 Nov; 44(3):243-9. PubMed ID: 7852968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disruption of the G1/S transition in human papillomavirus type 16 E7-expressing human cells is associated with altered regulation of cyclin E.
    Martin LG; Demers GW; Galloway DA
    J Virol; 1998 Feb; 72(2):975-85. PubMed ID: 9444990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.